THE YALE, CORIXA, IMUGEN CABAL KNEW LYMErix (OspA) CAUSED A CHRONIC-LYME-LIKE ILLNESS

OspA vaccine trials  were already underway in 1993; 1994 was the Dearborn conference where the neurologic case definition was thrown out with no one's approval.  Alan Barbour and Durland Fish set up the vaccine damage cases for abuse in 1993: BarbourFishpdf.pdf

 

1) Ben Luft at the 1998 FDA Meeting on Lyme and LYMErix:

http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3422t1.rtf

BEN LUFT: "The point that I wanted to make in regard to the study is that there is very heavy dependence on serologic confirmation. And when we start thinking about the adverse events, *** it was stated originally when we got the overview of the disease that the disease is really quite protean. And actually the adverse events are very similar to what the disease manifestations are.**** And if you start to, as I think Dr. Hall was eluding to -- if you start to kind of say well how often do you actually become seropositive, you can start to have a different take on when someone has an adverse event or whether it is disease specific or infection specific versus vaccine specific. And I think that that is an important issue that we have to deal with. ..."

 

2)  Yale's Robert Schoen says in 1998 not to test LYMErix victims and minimizes their symptoms knowing chronic Lyme is identical to what Schoen says is "nonspecific" because the exact reverse statement is in the Corixa-RICO patent "multisystem complaints characteristic of late Lyme",  This is that textbook:
http://www.amazon.com/Lyme-Disease-Key-Diseases-Series/dp/0943126584/ref=sr_1_fkmr0_2?ie=UTF8&qid=1341914626&sr=8-2-fkmr0&keywords=lyme+disease+rhan+and+evans

http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm

 

3)  Dave Persing (partners with Yale's Schoen in L2 Diagnostics) discussing why you should not use the native or original Osps/TLR2-agonists as vaccines (and Robert Schoen would know this too):

"Accordingly, the methods of the invention provide a powerful and selective approach for modulating the innate immune response pathways in animals without giving rise to the toxicities often associated with the native bacterial components that normally stimulate those pathways."  
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/PTO/srchnum.htm&r=1&f=G&l=50&s1=6,800,613.PN.&OS=PN/6,800,613&RS=PN/6,800,613




4) Persing and Schoen's RICO strain and monopoly on post-LYMErix blood patent
http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804

"Additional uncertainty may arise if the vaccines are not completely protective; vaccinated patients with multisystem complaints characteristic of later presentations of Lyme disease may be difficult to distinguish from patients with vaccine failure....

Schoen participated in that study in 1994.

Here are those 4 "we can't read our OspA vaccine results" reports:

1) SCHOEN and PERSING, with JOHN ANDERSON,1996 - the RICO report:
http://jcm.asm.org/cgi/reprint/35/1/233?view=long&pmid=8968914
2) SCHOEN AND PERSING IN THEIR 1996 RICO METHOD PATENT:
The Dave Persing, Mayo Clinic FRAUD Patent-6,045,804 
3) PERSING WITH SIGAL EXPLAINING THAT THE WESTERN BLOTS WERE UNREADABLE, 2000:
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920
4) Yale's ROBERT SCHOEN in the 1998 Munchausen's Book, instructing MDs to blow off LYMErix systemically injured people ("but send the post-vaccination blood to the Yale L2 Diagnostics RICO lab if you must bother to be a physician").

5) the Corixa advertisement where they sell a new adjuvant product that is not a TLR2-agonist > bottom of this page)  11.6 million dollar biodefense contract to NOT produce and sell OspA as an adjuvant because it was a fungal toxin:
http://www.actionlyme.org/CORIXA_NIH_BIODEFENCE.pdf
 

SmithKline bought Corixa to keep all that OspA-failure-and-harm data proprietary.

6)  The Phase IV of the LYMErix trial. Schoen says the adverse events were as described by Allen Steere, which means he does not consider the Chronic Neurologic Lyme outcomes of LYMErix.  Please read the whole report carefully:  OspA_4.htm


7) Munchausen's accusations against people they clearly knew were sick (1998) in this book, which was a set up such that later, when people's children became sick from the LYMErix vaccine, the parents could be blamed:

http://www.amazon.com/Lyme-Disease-Key-Diseases-Series/dp/0943126584/ref=sr_1_fkmr0_2?ie=UTF8&qid=1341914626&sr=8-2-fkmr0&keywords=lyme+disease+rhan+and+evans

http://www.actionlyme.org/MUNCHAUSENS.htm

On the previous page of this Munchausen's book:

 

Study hard, my people.  These douchebags are going to jail and this is why...

 

8) Steere says "seronegative Lyme is a conflict in terms when talking about arthritis" meaning that after the Dearborn conference,
"Lyme Disease" officially became the arthritis, only (in the Munchausen's/Schoen lies book here>>
http://www.amazon.com/Lyme-Disease-Key-Diseases-Series/dp/0943126584/ref=sr_1_fkmr0_2?ie=UTF8&qid=1341914626&sr=8-2-fkmr0&keywords=lyme+disease+rhan+and+evans



Seronegative Lyme disease is a subtle, attenuated illness, says Steere, in 1998.  He means "low antibody concentration" - see the Western Blots in the RICO complaint to see the difference:  http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm 

Steere was at this 1994 FDA meeting:

1994 FDA Meeting Transcripts where Ray Dattwyler tells the FDA Vaccine Committee that the
patients with low or no antibodies are the sickest:  http://www.actionlyme.org/Dattwyler_Luft_DNA_in_CSF.htm